D-PENICILLAMINE-INDUCED HEPATITIS IN A CHILD WITH WILSON'S DISEASE - SUCCESSFUL THERAPEUTIC SWITCH TO TRIENTINE.Published in:Current Therapeutics, 2023, v. 26, n. 4, p. 15By:Jayaprakash, Kavitha;Rajwal, SanjayPublication type:Article
SUCCESSFUL LONG-TERM TREATMENT OF AN ADOLESCENT WITH WILSON'S DISEASE AFTER THERAPY CHANGE FOLLOWING D-PENICILLAMINE-ASSOCIATED SIDE EFFECTS.Published in:Current Therapeutics, 2023, v. 26, n. 4, p. 12By:Pfister, Eva-DoreenPublication type:Article
SWITCHING FROM ZINC SALT TO TRIENTINE TETRAHYDROCHLORIDE IN WILSON'S DISEASE: CASE REPORT OF POOR ADHERENCE.Published in:Current Therapeutics, 2023, v. 26, n. 4, p. 7By:Sapuppo, AnnamariaPublication type:Article
MULTIPLE TREATMENT SWITCHES IN A WILSON'S DISEASE PATIENT.Published in:Current Therapeutics, 2023, v. 26, n. 4, p. 5By:Couchonnal, EduardoPublication type:Article
WILSON'S DISEASE - HOW TO CHOOSE THE MOST SUITABLE TREATMENT? DESCRIPTION OF A CHILD INTOLERANT TO ZINC AND D-PENICILLAMINE.Published in:Current Therapeutics, 2023, v. 26, n. 4, p. 2By:Socha, Piotr;Janczyk, WojciechPublication type:Article